Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Oncotarget|November 12, 2016
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signalingMaria Cristina Manara, Mario Terracciano, Caterina Mancarella, et al.
Current Pharmaceutical Biotechnology|February 17, 2012
Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cellsMara Gellini, Alessandro Ascione, Michela Flego, et al.
Molecular Endocrinology (Baltimore, Md.)|July 17, 2012
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcomaCecilia Garofalo, Caterina Mancarella, Andrea Grilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cellsKatia Scotlandi, Stefania Perdichizzi, Maria Cristina Manara, et al.
Cancer Gene Therapy|March 16, 2002
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cellsKatia Scotlandi, Cecilia Maini, Maria Cristina Manara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcomeKatia Scotlandi, Daniel Remondini, Gastone Castellani, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
The American Journal of Pathology|March 14, 2002
The expression of ccn3(nov) gene in musculoskeletal tumorsMaria Cristina Manara, Bernard Perbal, Stefania Benini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
Applied Microbiology and Biotechnology|December 22, 2015
Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcomaDiego Moricoli, Damiano Cosimo Carbonella, Sabrina Dominici, et al.
Pageof 8